Factor Therapeutics Overview

  • Status
  • Public
  • Stock Symbol
  • FTT
Stock Symbol

Factor Therapeutics General Information

Description

Factor Therapeutics Ltd is a biotechnology company. It is engaged in the development and commercialization of the Company's proprietary intellectual property in wound healing and tissue regeneration. The company earns revenue in the form of Interest.

Contact Information

Formerly Known As
Tissue Therapies
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
ASX
Primary Office
  • Brisbane, Ontario
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Factor Therapeutics Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.64M 1.04B 11M

Factor Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 30-Jun-2017
EV 1,346 63 (664) 29,390
EBITDA 1,160 (8,181) (4,245)
Net Income 1,160 (8,178) (4,216)
Total Assets 2,194 1,956 8,590
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Factor Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Christian Behrenbruch Ph.D Executive Director
To view Factor Therapeutics’s complete executive team members history, request access »